Biotech · Private company · Vienna, VA, US
ReveraGen BioPharma, Inc.
Track this companyFree. Adds ReveraGen BioPharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- PrednisonePhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- VamorolonePhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- VamorolonePhase 2 · Becker Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 0.25 mg/day/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 0.25 mg/kg/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 0.75 mg/day/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 0.75 mg/kg/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 2.0 mg/day/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 2.0 mg/kg/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 6.0 mg/day/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
- Vamorolone 6.0 mg/kg/dayPhase 2 · Duchenne Muscular DystrophyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)PHASE2 · COMPLETED · started Jul 7, 2022ClinicalTrials.gov NCT05166109 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)PHASE2 · COMPLETED · started Jun 29, 2018ClinicalTrials.gov NCT03439670 · fetched Nov 12, 2026
- Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)PHASE2 · COMPLETED · started Feb 2, 2017ClinicalTrials.gov NCT03038399 · fetched Nov 12, 2026
- An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)PHASE2 · COMPLETED · started Jul 28, 2016ClinicalTrials.gov NCT02760277 · fetched Nov 12, 2026
- A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)PHASE2 · COMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT02760264 · fetched Nov 12, 2026
NIH awards1
- Vamorolone trial in Becker muscular dystrophyFiscal year 2024 · $601.2KNIH RePORTER 5R01FD007284-02 · fetched Nov 12, 2026